Vivos Therapeutics, Inc. (VVOS) Stock Ticker
VVOS right now
Market factors today
Unlock the full VVOS picture
About Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
VVOS stock facts
| Ticker symbol | VVOS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $2.0M |
| CEO | R. Kirk Huntsman |
| Employees | 268 |
| Headquarters | Littleton, CO, US |
| IPO date | 2020-12-11 |
| Website | www.vivos.com |
What you can see for VVOS on Tickr
Live VVOS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the VVOS report.
Rankings
FAQ
What is the ticker symbol for Vivos Therapeutics, Inc.?
The ticker symbol for Vivos Therapeutics, Inc. is VVOS, listed on the NASDAQ.
What is VVOS?
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and…